JNJ logo

JNJ
Johnson & Johnson

48,601
Mkt Cap
$574.86B
Volume
2.55M
52W High
$251.71
52W Low
$146.12
PE Ratio
21.61
JNJ Fundamentals
Price
$233.77
Prev Close
$238.67
Open
$238.50
50D MA
$241.29
Beta
0.05
Avg. Volume
7.75M
EPS (Annual)
$11.03
P/B
7.05
Rev/Employee
$668,877.84
$533,647.35
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of $2.14 down -53.17% YoY • Reported revenue of $24.06B up 9.91% YoY • Johnson & Johnson increases 2026 guidance with estimated reported sales of $100.8B or 7.0% at the midpoint, and adjusted EPS of $11.55 or 7.1% at the midpoint.

Bullish

Johnson & Johnson achieved strong Q1 2026 reported sales growth of 9.9% and operational growth of 6.4%, driven by multiple new product approvals and robust performance across its Innovative Medicine and MedTech segments.

Bearish

Johnson & Johnson's Q1 2026 GAAP net earnings and diluted EPS declined over 52%, impacted by significant restructuring expenses, litigation, and a substantial decrease in STELARA sales.

Latest JNJ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.